GEODE CAPITAL MANAGEMENT, LLC

Holdings History for TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI)

Symbol: TLSI on Nasdaq
Investment type: Equity / Common stock, $0.0001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$5,245,335	751,207	+196,752	+35%	$6.98	Q4 2025
30 Sep 2025	0%	+0%	$2,578,591	554,455	+99,404	+22%	$4.65	Q3 2025
30 Jun 2025	0%	+0%	$2,480,299	455,051	+235,627	+107%	$5.45	Q2 2025
31 Mar 2025	0%	+0%	$1,211,554	219,424	+15,287		$5.52	Q1 2025
31 Dec 2024	0%	+0%	$1,023,028	204,137	+3,710	+1.9%	$5.01	Q4 2024
30 Sep 2024	0%	+0%	$924,191	200,427	+62,542	+45%	$4.61	Q3 2024
30 Jun 2024	0%	+0%	$761,405	137,885	+3,786	+2.8%	$5.52	Q2 2024
31 Mar 2024	0%	+0%	$1,307,942	134,099	+8,337	+6.6%	$9.75	Q1 2024
31 Dec 2023	0%	+0%	$1,063,067	125,762	+108,523	+630%	$8.45	Q4 2023
30 Sep 2023	0%	+0%	$88,263	17,239	+17,239	NEW	$5.12	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.